Adipocytokine levels in women with anorexia nervosa. Relationship with weight restoration and disease duration

International Journal of Eating Disorders

Volumn 46, Issue 8, 2013, Pages 855-861

  Terra, Ximena ^a   Auguet, Teresa ^a   Agüera, Zaida ^b   Quesada, Isabel Maria ^a   Orellana Gavaldà, Josep Maria ^a   Aguilar, Carmen ^a   Jiménez Murcia, Susana ^b,c,d   Berlanga, Alba ^a   Guiu Jurado, Esther ^a   Menchõn, José Manuel ^b,c,d   Fernández Aranda, Fernando ^b,c,d   Richart, Cristõbal ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Hospital Universitari Bellvitge IDIBELL   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

adipocytokines; anorexia nervosa; weight restoration

Indexed keywords

ADIPONECTIN; FATTY ACID BINDING PROTEIN 4; GHRELIN; INTERLEUKIN 6; LEPTIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RESISTIN; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ANOREXIA NERVOSA; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; EATING HABIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UNDERWEIGHT; WEIGHT CONTROL;

ADIPOCYTOKINES; ANOREXIA NERVOSA; WEIGHT RESTORATION;

ADIPOKINES; ADIPONECTIN; ADULT; ANOREXIA NERVOSA; BIOLOGICAL MARKERS; BODY MASS INDEX; BODY WEIGHT; CASE-CONTROL STUDIES; FATTY ACID-BINDING PROTEINS; FEMALE; GHRELIN; HUMANS; INTERVIEW, PSYCHOLOGICAL; LEPTIN; RESISTIN; RISK ASSESSMENT; SPAIN;

EID: 84888203126     PISSN: 02763478     EISSN: 1098108X     Source Type: Journal    
DOI: 10.1002/eat.22166     Document Type: Article

References (40)

1. Frampton I, Watkins B, Gordon I, Lask B,. Do abnormalities in regional cerebral blood flow in anorexia nervosa resolve after weight restoration? Eur Eat Disord Rev 2011; 19: 55-58.
2. Nordbø RHS, Espeset EMS, Gulliksen KS, Skårderud F, Geller J, Holte A,. Reluctance to recover in anorexia nervosa. Eur Eat Disord Rev 2011; 20: 60-67.
3. Brichard SM, Delporte ML, Lambert M,. Adipocytokines in anorexia nervosa: A review focusing on leptin and adiponectin. Horm Metab Res 2003; 35: 337-342.
4. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF,. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
5. Broch M, Auguet MT, Ramírez R, Olona M, Aguilar C, Megia A, et al. Parallel downregulation of retinol-binding protein-4 and adiponectin expression in subcutaneous adipose tissue of non-morbidly obese subjects. Eur J Endocrinol 2009; 161: 87-94.
6. Kowalska I, Karczewska-Kupczewska M, Stra̧czkowski M,. Adipocytokines, gut hormones and growth factors in anorexia nervosa. Clin Chim Acta 2011; 412: 1702-1711.
7. Nedvídková J, Smitka K, Kopský V, Hainer V,. Adiponectin, an adipocyte-derived protein. Physiol Res 2005; 54: 133-140.
8. Tagami T, Satoh N, Usui T, Yamada K, Shimatsu A, Kuzuya H,. Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2004; 89: 1833-1837.
9. Iwahashi H, Funahashi T, Kurokawa N, Sayama K, Fukuda E, Okita K, et al. Plasma adiponectin levels in women with anorexia nervosa. Horm Metab Res 2003; 35: 537-540.
10. Wåhlen K, Sjölin E, Löfgren P,. Role of fat cell size for plasma leptin in a large population based sample. Exp Clin Endocrinol Diabetes 2011; 119: 291-294.
11. Ziora K, Oświȩcimska J, Swiȩtochowska E, Ziora D, Stojewska M, Suwała A, et al. Assessment of serum visfatin levels in girls with anorexia nervosa. Clin Endocrinol 2012; 76: 514-519.
12. Schwartz DR, Lazar MA,. Human resistin: Found in translation from mouse to man. Trends Endocrinol Metab 2011; 22: 259-265.
13. Dostálová I, Kunesova M, Duskova J, Papezova H, Nedvídková J,. Adipose tissue resistin levels in patients with anorexia nervosa. Nutrition 2006; 22: 977-983.
14. Dolezalová R, Lacinova Z, Dolinkova M, Kleiblova P, Haluzíková D, Housa D, et al. Changes of endocrine function of adipose tissue in anorexia nervosa: Comparison of circulating levels versus subcutaneous mRNA expression. Clin Endocrinol 2007; 67: 674-678.
15. Ondrak KS, Hackney AC,. Body composition differences in normal weight, obese-overweight and anorexic adolescents: Role of adipocytokines. Med Sport Sci 2010; 55: 32-42.
16. Misra M, Miller KK, Tsai P, Stewart V, End A, Freed N, et al. Uncoupling of cardiovascular risk markers in adolescent girls with anorexia nervosa. J Pediatr 2006; 149: 763-769.e1.
17. Agnello E, Malfi G, Costantino AM, Massarenti P, Pugliese M, Fortunati N, et al. Tumour necrosis factor alpha and oxidative stress as maintaining factors in the evolution of anorexia nervosa. Eat Weight Disord 2012; 17: e194-9.
18. Karczewska-Kupczewska M, Adamska A, Nikołajuk A, Otziomek E, Gõrska M, Kowalska I, et al. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa. Clin Endocrinol 2012, 10.1111/CEN.12118.
19. Yi CX, Heppner K, Tschöp MH,. Ghrelin in eating disorders. Mol Cell Endocrinol 2011; 340: 29-34.
20. Uehara M, Yasuhara D, Nakahara T, Harada T, Koyama KI, Ushikai M, et al. Increase in energy intake leads to a decrease in obestatin in restricting-type of anorexia nervosa. Exp Clin Endocrinol Diabetes 2011; 119: 536-539.
21. Auguet T, Quintero Y, Terra T, Martínez S, Lucas A, Pellitero S, et al. Upregulation of lipocalin-2 in adipose tissues of severely obese women: Positive relationship with proinflammatory cytokines. Obesity 2011; 19: 2295-2300.
22. Jin D, Guo H, Bu SY, Zhang Y, Hannaford J, Mashek DG, et al. Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-γ activation and function in lipid homeostasis and energy expenditure. FASEB J 2011; 25: 754-764.
23. Jang YS, Lee JH, Wang Y, Sweeney G,. Emerging clinical and experimental evidence for the role ofLipocalin-2 in metabolic syndrome. Clin Exp Pharmacol Physiol 2012; 39: 194-199.
24. Cowland JB, Muta T, Borregaard N,. IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. J Immunol 2006; 176: 5559-5566.
25. Terra X, Quintero Y, Auguet T, Porras JA, Hernández M, Sabench F, et al. FABP4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women. Eur J Endocrinol 2011; 164: 539-547.
26. Haluzíková D, Dostálová I, Kaválková P, Roubícek T, Mráz M, Papezová H, et al. Serum concentrations of adipocyte fatty acid binding protein in patients with anorexia nervosa. Physiol Res 2009; 58: 577-581.
27. First M, Gibbon M, Spitzer R, Williams J. Users Guide for the Structured Clinical Interview for DSM IV Axis I Disorders-Research Version (SCID-I, version 2.0). American Psychiatric Press, Inc., Washington, DC. 1996.
28. Wallace TM, Levy JC, Matthews DR,. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495.
29. Behre CJ,. Adiponectin, obesity and atherosclerosis. Scand J Clin Lab Invest 2007; 67: 449-458.
30. Delporte ML, Brichard SM, Hermans MP, Beguin C, Lambert M,. Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol 2003; 58: 22-29.
31. Housova J, Anderlova K, Krizová J, Haluzíková D, Kremen J, Kumstyrová T, et al. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2005; 90: 1366-1370.
32. Saito K, Arata S, Hosono T, Sano Y, Takahashi K, Choi-Miura NH, et al. Adiponectin plays an important role in efficient energy usage under energy shortage. Biochim Biophys Acta 2006; 1761: 709-716.
33. Modan-Moses D, Stein D, Pariente C, Yaroslavsky A, Ram A, Faigin M, et al. Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. J Clin Endocrinol Metab 2007; 92: 1843-1847.
34. Janas-Kozik M, Stachowicz M, Krupka-Matuszczyk I, Szymszal J, Krysta K, Janas A, et al. Plasma levels of leptin and orexin A in the restrictive type of anorexia nervosa. Regul Pept 2011; 168: 5-9.
35. Föcker M, Timmesfeld N, Scherag S, Bühren K, Langkamp M, Dempfle A, et al. Screening for anorexia nervosa via measurement of serum leptin levels. J Neural Transm 2011; 118: 571-578.
36. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002; 87: 240-244.
37. Gletsu LE,. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg 2004; 139: 780-784.
38. Kirchner H, Heppner KM, Tschop MH,. The role of ghrelin in the control of energy balance. Handb Exp Pharmacol 2012; 209: 161-184.
39. Peterli R, Steinert R, Woelnerhanssen B, Peters T, Christoffel-Courtin C, Gass M, et al. Metabolic and hormonal changes after laparoscopic roux-en-Y gastric bypass and sleeve gastrectomy: A randomized, prospective trial. Obes Surg 2012; 22: 740-748.
40. Nogueira JP, Maraninchi M, Lorec AM, Corroller AB, Nicolay A, Gaudart J, et al. Specific adipocytokines profiles in patients with hyperactive and/or binge/purge form of anorexia nervosa. Eur J Clin Nutr 2010; 64: 840-844.